DWS, the newly renamed exchange traded funds arm of Deutsche Bank AG (NYSE: DB), expanded its ETF roster Thursday with the debut of the Xtrackers Russell 1000
US QARP ETF (NYSE: QARP).
The new ETF tracks the Russell 1000 2Qual/Val 5% Capped Index. That benchmark “aims to identify companies that have strong
quality scores relative to their peers, while also looking at the value scores of the securities to avoid those quality companies
that are potentially overpriced,” according to DWS.
In other words, QARP looks to hold stocks with favorable quality and value traits while dodging value traps, or those stocks
that look like bargains but never recover to fair value.
Inside The New ETF
QARP holds 385 stocks, 25.8 percent of which are technology names. The industrial and health care sectors combine for a third of
the new ETF's weight. Consumer discretionary and consumer staples stocks combine for almost a quarter of QARP's roster.
Eight of QARP's top 10 holdings, a group that combines for about 26 percent of the fund's weight, include eight members of the
Dow Jones Industrial Average. Apple Inc. (NASDAQ: AAPL), Boeing Co. (NYSE: BA), Johnson & Johnson (NYSE: JNJ), Intel Corp. (NASDAQ: INTC) and Wal-Mart Stores Inc. (NYSE: WMT) are QARP's top five holdings.
“The launch of QARP adds to the existing Xtrackers comprehensive factor indices line-up, which is designed to track the equity
market performance of companies that have demonstrated relatively strong exposure to targeted investment style factors: value,
momentum, quality, volatility and size,” according to DWS.
A Favorable Fee
QARP charges 0.19 percent per year, or $19 on a $10,000 investment. That compares favorably with the broader universe of
domestic large-cap smart beta strategies.
QARP is the third ETF introduced by DWS this year and the first equity-based strategy. The firm introduced two bond ETFs earlier
this year.
Related Links:
Finding Value In
Healthcare ETFs
Be Bullish On
This Sector ETF
© 2018 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.